Potential Use of Exosomes as Diagnostic Biomarkers and in Targeted Drug Delivery: Progress in Clinical and Preclinical Applications | ACS Biomaterials Science & Engineering
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization | Nature Communications
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization | Nature Communications
Frontiers | Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization | Nature Communications
Vaccines | Free Full-Text | Assessing the Protective Dose of a Candidate DIVA Vaccine against Classical Swine Fever
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization | Nature Communications
Promoting safe working environments by tracking vaccination status • Fusion Learning Partners
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization | Nature Communications
A Natural Peptide Antigen within the Plasmodium Ribosomal Protein RPL6 Confers Liver TRM Cell-Mediated Immunity against Malaria in Mice - ScienceDirect
FAQ: DIVA vaccines and diagnostics - Epizone
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization | Nature Communications
Promoting safe working environments by tracking vaccination status • Fusion Learning Partners
Vaccines | Free Full-Text | Assessing the Protective Dose of a Candidate DIVA Vaccine against Classical Swine Fever
EURL activities of importance to the LSD diagnosis and vaccine control
Refining the approach to vaccines against influenza A viruses with pandemic potential | Future Virology
Full article: Tolerogenic vaccine composited with islet-derived multipeptides and cyclosporin A induces pTreg and prevents Type 1 diabetes in murine model
Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes | Science Immunology
Frontiers | Development of Recombinant Protein-Based Vaccine Against Classical Swine Fever Virus in Pigs Using Transgenic Nicotiana benthamiana
Vaccines | Free Full-Text | Vaccination with Deglycosylated Modified Hemagglutinin Broadly Protects against Influenza Virus Infection in Mice and Ferrets
